By Professor Janaki Amin

Conference Papers

Kumarasinghe G; Herrera CL; Stuart SE; Victor A; Amin J; Hayward CS; Macdonald PS; Danta M, 2011, 'NONINVASIVE ASSESSMENT OF LIVER FIBROSIS IN CARDIAC DISEASE', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 899A - 900A, presented at 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), CA, San Francisco, 04 November 2011 - 08 November 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295578003359&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ebeling PR; Haskelberg H; Hoy J; Amin J; Emery S; Carr A, 2011, 'LOWER FAT MASS AND LOWER BONE FORMATION PREDICT GREATER BONE LOSS WITH TENOFOVIR IN HIV-INFECTED ADULTS', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Gold Coast, pp. S614 - S615, presented at IOF Regionals 2nd Asia-Pacific Osteoporosis and Bone Meeting / ANZBMS Annual Scientific Meeting held with the JSBMR, AUSTRALIA, Gold Coast, 04 September 2011 - 08 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309258200234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Danta M; Kumarasinghe G; Victor A; Stuart SE; Amin J; Hayward CS; Macdonald PS, 2010, 'LIVER ELASTOGRAPHY IN CARDIAC DISEASE (LECD) STUDY', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 961A - 961A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 29 October 2010 - 02 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601658&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carey D; Amin J; Emery S, 2009, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir in randomized trials: systematic review and meta-analysis', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A58 - A58, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen VT; Amin J; Law MG; Dore GJ, 2008, 'Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A343 - A343

Nguyen VT; Razali K; Amin J; Law MG; Dore GJ, 2006, 'Estimates of Hepatitis B-Realted Liver Cancer Among Vietnam Born Population in Australia', in 18th Annual ASHM Conference, Melbourne, pp. 152 - 153, presented at 18th Annual ASHM Conference, Melbourne, 11 October 2006 - 14 October 2006

Amin J; Carr A; Hill A; Emery S; Law M; Cooper DA, 2002, 'Haematological changes in patients randomized to HAART regimens containing either zidovudine or stavudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L60 - L60, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Vaccher S; Holt M; Prestage G; Amin J; Selvey C; Zablotska-Manos I; Guy R; Jin F; Carr A; Grulich A; Bavinton B, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c

Vaccher S; Guy R; Templeton D; Zablotska-Manos I; Clackett S; Holt M; Prestage G; Amin J; Selvey C; Jin F; Grulich A; Bavinton B, 2019, 'Pre-exposure prophylaxis use among trans and gender diverse people: Characteristics and behaviour from the EPIC-NSW trial', Vancouver, Canada, presented at STI & HIV World Congress, Vancouver, Canada, 14 July 2019

Cunningham EB; Hajarizadeh B; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Bretana NA; Dolan K; Lloyd AR; Grebely J, 2018, 'Ongoing incident hepatitic c virus infection among people with a history of injecting drug use in an Australian prison setting', Vol. 1, pp. 278 - 280, http://dx.doi.org/10.1093/JCAG/GWY008.162

Conference Presentations

Arapali T; Amin J; Lockwood T; Varma R; Clackett S; Keen P; Broady T; Grulich A; Bavinton B, 2024, 'To innovation and beyond: alternative oral PrEP service delivery models and policy, legal, and regulatory considerations for their implementation in Australia', presented at Australasian HIV&AIDS Conference, 2024, Sydney, NSW, 16 September 2024 - 18 September 2024

Waziry R; Hajarizadeh B; Grebely J; Amin J; Law M; Danta M; George J; Dore GJ, 2017, 'No evidence for higher risk of hepatocellular carcinoma occurrence or recurrence following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression', presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30286-6

Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews G; Law M; Dore G; Law M, 2016, 'Survival following hepatocellular carcinoma among people with HBV or HCV in New South Wales, Australia between 2000 and 2014', presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016

Grebely J; Dalgard O; Conway B; Foster G; Bruggmann P; Backmund M; Robaeys G; Swan T; Hajarizadeh B; Amin J; Marks P; Quiene S; Weltman M; Shaw D; Dunlop A; Hellard M; Bruneau J; Bourgeois S; Thurnheer C; Dore GJ; Group OBOTACTIVATES, 2015, 'P0848 : Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCV genotype 2/3 infection: The activate study', presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, AUSTRIA, Vienna, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/s0168-8278(15)31050-3

Conference Abstracts

Lambeth C; Ellis S; Ennis S; Selvey C; Amin J, 2026, 'Population level impact of the 2025 NSW RSV prevention program', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, ELSEVIER SCIENCE INC, Vol. 50, pp. S24 - S25

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews G; Martinello M; Danta M; Amin J; Law M; George J; Innes H; Dore G, 2022, 'FRI339 Liver-related mortality among people with hepatitis B and C: a validation study using linked healthcare administrative datasets', in Journal of Hepatology, Elsevier, Vol. 77, pp. s560, http://dx.doi.org/10.1016/s0168-8278(22)01443-x

Carson J; Dore G; Lloyd A; Grebely J; Byrne M; Cunningham EB; Amin J; Vickerman P; Martin N; Treloar C; Matthews G; Hajarizadeh B, 2022, 'FRI349 Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study', in Journal of Hepatology, Elsevier, Vol. 77, pp. s565, http://dx.doi.org/10.1016/s0168-8278(22)01451-9

Alavi M; Valerio H; Law M; Lockart I; Danta M; Grebely J; Amin J; Hajarizadeh B; George J; Dore G, 2022, 'FRI356 Incidence and risk factors of hepatitis C liver morbidity and mortality in the era of direct-acting antiviral therapies: a population-based linkage study', in Journal of Hepatology, Elsevier, Vol. 77, pp. s568 - s569, http://dx.doi.org/10.1016/s0168-8278(22)01458-1

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews G; Martinello M; Danta M; Amin J; Law M; George J; Dore G, 2022, 'THU415 Trends in decompensated cirrhosis and hepatocellular carcinoma diagnosis among people with a hepatitis B notification in New South Wales: a population-based data linkage study', in Journal of Hepatology, Elsevier, Vol. 77, pp. s302, http://dx.doi.org/10.1016/s0168-8278(22)00971-0

He S; Alavi M; Hajarizadeh B; Grebely J; Law M; Amin J; George J; Danta M; Dore G, 2021, 'comparison of hbv-related hcc incidence between entecavir and tenofovir treated cohorts: a population-based study', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 75, pp. S515 - S516, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000667753801051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau A; Kong FYS; Fairley CK; Templeton DJ; Amin J; Phillips S; Law M; Chen MY; Bradshaw CS; Donovan B; McNulty A; Boyd MA; Timms P; Chow EPF; Regan DG; Khaw C; Lewis DA; Kaldor J; Ratnayake M; Carvalho N; Hocking JS, 2021, 'TREATMENT EFFICACY OF 1G AZITHROMYCIN VERSUS 100MG DOXYCYCLINE BI-DAILY FOR SEVEN DAYS FOR ASYMPTOMATIC RECTAL CHLAMYDIA TRACHOMATIS', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 18, pp. XX - XX, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693686000029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Di Ciaccio PR; Jin F; Law M; Van Leeuwen MT; Grulich A; Amin J; Vajdic C; McGregor S; Polizzotto MN, 2020, 'The role of lymphomas in subsequent primary cancers in people with HIV/AIDS: An Australian national population-based data linkage study', in Blood, American Society of Hematology, Vol. 136, pp. 32 - 32, presented at 62nd American Society of Hematology Annual Meeting, 05 December 2020 - 08 December 2020, http://dx.doi.org/10.1182/blood-2020-139012

He S; Dore G; Law M; Heahter V; Grebely J; Amin J; Hajarizadeh B; George J; Danta M; Alavi M, 2019, 'IMPROVED SURVIVAL FOLLOWING HEPATITIS C-RELATED HEPATOCELLULAR CARCINOMA DIAGNOSIS IN THE DIRECT-ACTING ANTIVIRAL THERAPY ERA IN NEW SOUTH WALES, AUSTRALIA', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 906A - 906A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653503195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

He S; Dore G; Law M; Valerio H; Grebely J; Amin J; Hajarizadeh B; George J; Danta M; Alavi M, 2019, 'Improved survival after hepatitis C-related hepatocellular carcinoma diagnosis in the direct-acting antiviral therapy era in New South Wales, Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grulich A; Jin F; Vaccher S; Bavinton B; Vickers T; Amin J; Selvey C; Chant K; Zablotska-Manos I; Baker D; Bloch M; Carr A; Smith D; Guy R, 2019, 'Continuing low HIV incidence in the expanded pre-exposure prophylaxis (PrEP) implementation in communities New South Wales study (EPIC-NSW)', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 22, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476890500057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bavinton B; Vaccher S; Prestage G; Holt M; Guy R; Amin J; Selvey C; Zablotska-Manos I; Jin F; Carr A; Templeton D; Grulich A, 2019, 'Factors associated with stopping HIV pre-exposure prophylaxis (PrEP) for three months or more in the EPIC-NSW trial', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 22, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476890500063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'Reinfection following successful HCV DAA therapy among people with recent injecting drug use', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E732 - E733, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bavinton B; Vaccher S; Holt M; Guy R; Prestage G; Jin F; Amin J; Templeton D; Selvey C; Zablotska-Manos I; Lusk J; Ogilvie E; Vickers T; Smith D; Grulich A, 2019, 'P435 Use of condoms for the prevention of Sexually Transmitted Infections (STIs) among HIV Pre-Exposure Prophylaxis (PrEP) users', in Sexually Transmitted Infections, BMJ, Vol. 95, pp. a206, presented at Poster Presentations, http://dx.doi.org/10.1136/sextrans-2019-sti.521

Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'PS-070-Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in Journal of Hepatology, Elsevier, Vol. 70, pp. e42, http://dx.doi.org/10.1016/s0618-8278(19)30076-3

Vaccher S; Amin J; Guy R; Jin F; Selvey C; Zablotska-Manos I; Holden J; Price K; Yeung B; Levitt G; Ogilvie E; McNulty A; Smith D; Cooper D; Grulich A, 2018, 'Baseline preferences for daily and non-daily PrEP dosing in EPIC-NSW', in Australasian HIV and AIDS Conference Handbook, Sydney, Australia, presented at Australasian HIV and AIDS Conference, Sydney, Australia, 26 September 2018, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/36f06f6908734ab9a17095cab8705e35

Dalgard O; Grebely J; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and Velpatasvir for Hepatitis C Virus Infection in People with Recent Injecting Drug Use (Simplify): An Open-Label, Single-Arm, Phase 4, Multicentre Trial', in HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, PACINI EDITORE, Vol. 20, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440974900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin AH; Dillon JF; Read P; Gane ED; Dore GJ, 2017, 'EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN PEOPLE WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT INJECTING DRUG USE: THE SIMPLIFY STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer CM; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2017, 'Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S513 - S513, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017

Lamoury FM; Hajarizadeh B; Soker A; Martinez D; Quek C; Cunningham P; Catlett B; Cloherty GA; Marks P; Amin J; Grebely J; Dore GJ; Applegate TL, 2017, 'SAT-207 Hepatitis C virus core antigen and dried blood spots as simplified hepatitis C virus diagnostic tools', in Journal of Hepatology, Elsevier, Vol. 66, pp. s710, http://dx.doi.org/10.1016/s0168-8278(17)31901-3

Larney S; Grebely J; Degenhardt L; Amin J; Law M; Alavi M; Dore GJ; Law M, 2016, 'EXPOSURE TO OPIOID SUBSTITUTION THERAPY FOLLOWING HEPATITIS C NOTIFICATION: IMPLICATIONS FOR PROVISION OF ANTIVIRAL THERAPIES IN DRUG TREATMENT SETTINGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 48 - 48

Zablotska I; Grulich AE; Guy R; Amin J; Selvey C; Schmidt H-M; Price K; Cooper D, 2016, 'Expanded PrEP implementation in communities in NSW, Australia (EPIC-NSW): evidence-based implementation study', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000395394300219&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Alavi M; Janjua N; Yu A; Grebely J; Aspinall E; Innes H; Valerio H; Hayes P; Krajden M; Amin J; Law M; George J; Goldberg D; Hutchinson S; Dore G, 2016, 'FRI-417 Does Alcohol Dependency Explain Differences in Rates of Decompensated Cirrhosis among People with a Hepatitis C Notification? An International Comparison', in Journal of Hepatology, Elsevier, Vol. 64, pp. s462 - s463, http://dx.doi.org/10.1016/s0168-8278(16)00776-5

Muscatello DJ; Amin J; MacIntyre CR; Newall AT; Rawlinson WD; Sintchenko V; Gilmour R; Thackway S, 2014, 'Under-ascertainment of Illness due to Influenza in Administrative Databases, a Population-based Record Linkage Study', in Online J Public Health Inform, University of Illinois at Chicago Library, Vol. 6, pp. e169, http://dx.doi.org/10.5210/ojphi.v6i1.5189

Grulich A; McCredie M; Van Leeuwen MT; Amin J; Stewart J; McDonald S; Webster A; Kaldor J; Chapman J; Vajdic C, 2008, 'Rates of human papillomavirus (HPV)-related cancers are increased in renal transplant recipients and return to low levels on cessation of immune suppression', in Transplantation, Lippincott, Williams & Wilkins, Sydney, Vol. 86, pp. 295 - 295, presented at XXII International Congress of The Transplantation Society, Sydney, 10 August 2008 - 14 August 2008, http://dx.doi.org/10.1097/01.tp.0000331938.42935.c5

Van Leeuwen MT; Vajdic C; Webster A; McDonald S; McCredie M; Stewart J; Amin J; Kaldor J; Chapman J; Grulich A, 2008, 'Risk for Non-Hodgkin lymphoma following renal transplantation is associated with currency of receipt of immunosuppression and reverts to normal on cessation', in Transplantation, Lippincott, Williams & Wilkins, Sydney, Vol. 86, pp. 294 - 294, presented at XXII International Congress of The Transplantation Society, Sydney, 10 August 2008 - 14 August 2008, http://dx.doi.org/10.1097/01.tp.0000331934.97193.4e

Vajdic C; Van Leeuwen MT; Amin J; McDonald S; McCredie M; Stewart J; Webster A; Kaldor J; Chapman J; Grulich A, 2008, 'Risk of cutaneous melanoma does not increase over time after renal transplantation', in Transplantation, Lippincott, Williams & Wilkins, Sydney, Vol. 86, pp. 296 - 296, presented at XXII International Congress of The Transplantation Society, Sydney, 10 August 2008 - 14 August 2008, http://dx.doi.org/10.1097/01.tp.0000331939.20064.c4

Van Leeuwen MT; Grulich A; Webster A; McDonald S; McCredie M; Stewart J; Amin J; Kaldor J; Chapman J; Vajdic C, 2008, 'Currency of receipt of immunosuppressive agents and other risk factors for lip cancer following renal transplantation', Sydney, presented at XXII International Congress of The Transplantation Society, Sydney, 10 August 2008 - 14 August 2008, http://dx.doi.org/10.1097/01.tp.0000332547.88129.b9

Micallef JM; Jauncey M; Amin J; Rawlinson W; Gilmour S; van Beek I; Kaldor JM; White PA; Dore GJ, 2003, 'Hepatitis C virus reinfection within a cohort of injecting drug users.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, Vol. 38, pp. 266A - 266A, presented at 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, MASSACHUSETTS, BOSTON, 24 October 2003 - 28 October 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000185816700230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Theses / Dissertations

Muscatello DJ, 2014, Improving seasonal and pandemic influenza surveillance, epidemiology and disease burden estimation in populations using administrative and vital statistics databases and population surveys

Preprints

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Group S-CS, 2020, Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the SToP-C Study, http://dx.doi.org/10.2139/ssrn.3709824

Imai C; Amin J; Prgomet M; Pearce C; Georgiou A, Antibiotic prescribing for respiratory tract infections through telehealth consultations: A retrospective study in Australian general practice. (Preprint), http://dx.doi.org/10.2196/preprints.40876

Liu B; Stepien S; Qian J; Gidding H; Nicolopoulos K; Amin J; Cheng A; Macartney K, Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection, http://dx.doi.org/10.1101/2022.12.22.22283869

Lystad RP; Fajardo Pulido D; Peters L; Johnstone M; Ellis LA; Braithwaite J; Wuthrich V; Amin J; Cameron CM; Mitchell RJ, Feasibility of Monitoring Health and Well-being in Emerging Adults: Pilot Longitudinal Cohort Study (Preprint), http://dx.doi.org/10.2196/preprints.30027

Back to profile page